Correlation Between Vaccinex and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Molecular Partners AG, you can compare the effects of market volatilities on Vaccinex and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Molecular Partners.
Diversification Opportunities for Vaccinex and Molecular Partners
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Vaccinex and Molecular is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Vaccinex i.e., Vaccinex and Molecular Partners go up and down completely randomly.
Pair Corralation between Vaccinex and Molecular Partners
Given the investment horizon of 90 days Vaccinex is expected to generate 1.43 times more return on investment than Molecular Partners. However, Vaccinex is 1.43 times more volatile than Molecular Partners AG. It trades about 0.0 of its potential returns per unit of risk. Molecular Partners AG is currently generating about -0.01 per unit of risk. If you would invest 403.00 in Vaccinex on August 31, 2024 and sell it today you would lose (34.00) from holding Vaccinex or give up 8.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vaccinex vs. Molecular Partners AG
Performance |
| Timeline |
| Vaccinex |
| Molecular Partners |
Vaccinex and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vaccinex and Molecular Partners
The main advantage of trading using opposite Vaccinex and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.| Vaccinex vs. Protara Therapeutics | Vaccinex vs. Monopar Therapeutics | Vaccinex vs. Surrozen | Vaccinex vs. Salarius Pharmaceuticals |
| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |